interferon alfa-2b
Merck has discontinued all presentations of Intron A solution for injection. They expect product to be depleted by mid- to late-July 2021.
Merck has discontinued all presentations of Intron A powder for injection. They expect product to be depleted by mid- to late-March 2022.
Merck has discontinued all presentations of Intron A solution for injection. They expect product to be depleted by mid- to late-July 2021.
Merck has discontinued all presentations of Intron A powder for injection. They expect product to be depleted by mid- to late-March 2022.